Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
ROCHE on Wednesday forecast that profit growth would not outstrip sales in 2017 as the world's top cancer drugmaker increases spending on new products that it hopes will offset declines in ageing biotech medicines now going off patent.
The Swiss drugmaker dismissed...